Eisai
4523.T
#2011
Rank
NZ$13.78 B
Marketcap
$48.91
Share price
-0.53%
Change (1 day)
-36.38%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : NZ$5.77 Billion

According to Eisai's latest financial reports the company's total liabilities are NZ$5.77 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31NZ$5.27 B-4.03%
2022-03-31NZ$5.49 B17.16%
2021-03-31NZ$4.69 B-15.22%
2020-03-31NZ$5.53 B-0.35%
2019-03-31NZ$5.55 B-1.66%
2018-03-31NZ$5.65 B3.31%
2017-03-31NZ$5.46 B6.83%
2016-03-31NZ$5.12 B2.03%
2015-03-31NZ$5.01 B0.72%
2014-03-31NZ$4.98 B-23.77%
2013-03-31NZ$6.53 B-23.5%
2012-03-31NZ$8.54 B-14.86%
2011-03-31NZ$10.03 B-2.44%
2010-03-31NZ$10.28 B-20.25%
2009-03-31NZ$12.89 B50.85%
2008-03-31NZ$8.55 B214.06%
2007-03-31NZ$2.72 B-13.68%
2006-03-31NZ$3.15 B18.54%
2005-03-31NZ$2.66 B-5.84%
2004-03-31NZ$2.82 B-9.26%
2003-03-31NZ$3.11 B-1.83%
2002-03-31NZ$3.17 B-21.63%
2001-03-31NZ$4.04 B